Genomics in Scotland strategy: business and regulatory impact assessment
Business and regulatory impact assessment (BRIA) for the Genomics in Scotland: Building our Future five-year national strategy (2024 to 2029).
10. Digital Impact Test
The strategy, by embracing innovation and digital opportunity, will enable the adoption of potential new genomic and informatic technologies during its lifetime, as well as the movement of some services online. As the strategy is aiming to improve service delivery and patient outcomes, it is expected the impact will be positive. The risk of widening the ‘digital divide’ has been recognised and our approach to digital health will be guided by the Digital Healthcare Strategy (2021) including the development of the Digital Front Door, which will be a key enabler for people interacting with health and social care services in Scotland.
Contact
Email: holly.ennis@gov.scot
There is a problem
Thanks for your feedback